Literature DB >> 10751391

GABAA and alpha-amino-3-hydroxy-5-methylsoxazole-4-propionate receptors are differentially affected by aging in the rat hippocampus.

D Ruano1, F Araujo, E Revilla, J Vela, O Bergis, J Vitorica.   

Abstract

We have investigated the age-dependent modifications in the expression of eight different subunits of the gamma-aminobutyric acid, type A (GABA(A)) receptor (alpha1, alpha2, alpha3, alpha5, beta2, beta3, gamma2S, and gamma2L) and all four subunits of the alpha-amino-3-hydroxy-5-methylsoxazole-4-propionate (AMPA) receptor (GluR1-4) in the hippocampus of 24-month-old rats. All aged hippocampi displayed a remarkable increase (aged/adult ratio, 3.53 +/- 0.54) in the mRNA levels of the short version of the gamma2 subunit in parallel with a similar increase in the gamma2 subunit protein (aged/adult ratio, 2.90 +/- 0.62). However, this increase was not observed in the mature receptor. On the other hand, the expression of the different alpha subunit mRNAs increased moderately with aging, displaying a heterogeneous pattern. The most frequent modification consisted in an increase in the expression of the alpha1 subunit mRNA (aged/adult ratio, 1.26 +/- 0.18), in parallel with a similar increase on the alpha1 protein (aged/adult ratio, 1. 27 +/- 0.12) and in the alpha1 incorporated to the assembled GABA(A) receptor (tested by immunoprecipitation; aged/adult ratio, = 1.20 +/- 0.10). However, in the same hippocampal samples, no major modifications were observed on the expression of the AMPA receptor subunits. As a whole, these results indicated the existence of an increased expression of the GABA(A) receptor subunits and a preservation of the AMPA receptor at the hippocampal formation. These modifications could reflect the existence of specific deficiencies (neuronal loss and/or deafferentiation) on the GABAergic system in the aged rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751391     DOI: 10.1074/jbc.M000700200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Does aging alter the molecular substrate of ionotropic neurotransmitter receptors in the rostral ventral lateral medulla? - A short communication.

Authors:  Hitesh N Pawar; Sivasai Balivada; Michael J Kenney
Journal:  Exp Gerontol       Date:  2017-03-02       Impact factor: 4.032

Review 2.  Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer's disease.

Authors:  Robert A Rissman; William C Mobley
Journal:  J Neurochem       Date:  2011-03-28       Impact factor: 5.372

3.  Zolpidem generalization and antagonism in male and female cynomolgus monkeys trained to discriminate 1.0 or 2.0 g/kg ethanol.

Authors:  Christa M Helms; Laura S M Rogers; Courtney A Waters; Kathleen A Grant
Journal:  Alcohol Clin Exp Res       Date:  2008-07       Impact factor: 3.455

4.  Reversal of Age-Related Neuronal Atrophy by α5-GABAA Receptor Positive Allosteric Modulation.

Authors:  Thomas D Prevot; Akiko Sumitomo; Toshifumi Tomoda; Daniel E Knutson; Guanguan Li; Prithu Mondal; Mounira Banasr; James M Cook; Etienne Sibille
Journal:  Cereb Cortex       Date:  2021-01-05       Impact factor: 5.357

Review 5.  The space where aging acts: focus on the GABAergic synapse.

Authors:  Aleksandra Rozycka; Monika Liguz-Lecznar
Journal:  Aging Cell       Date:  2017-05-12       Impact factor: 9.304

6.  GABA(A) receptor-mediated acceleration of aging-associated memory decline in APP/PS1 mice and its pharmacological treatment by picrotoxin.

Authors:  Yuji Yoshiike; Tetsuya Kimura; Shunji Yamashita; Hiroyuki Furudate; Tatsuya Mizoroki; Miyuki Murayama; Akihiko Takashima
Journal:  PLoS One       Date:  2008-08-21       Impact factor: 3.240

7.  The effect of age and sex on the expression of GABA signaling components in the human hippocampus and entorhinal cortex.

Authors:  Jayarjun Ethiraj; Thulani Hansika Palpagama; Clinton Turner; Bert van der Werf; Henry John Waldvogel; Richard Lewis Maxwell Faull; Andrea Kwakowsky
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.